A team led by the Institute for Protein Design devised machine-learning algorithms that created light-emitting enzymes called luciferases.
Nanoparticle technology created by researchers at the University of Washington School of Medicine is featured in a vaccine for respiratory syncytial virus (commonly known as RSV).
Controlling when and where an immune-prompting molecule is active may make treatment safer, more effective.
Papers in Science show how machine learning can accelerate solutions for protein design challenges.
Machine learning, used to design proteins with a variety of functions, is doing things scientists didn't realize it was capable of.
SKbioscience’s SKYCovione vaccine becomes the first therapeutic OK'd for people to emerge from the Institute for Protein Design.
A new method for generating potent, specific binding proteins yields candidate medicines for cancer, diabetes, inflammation and more.
A neural network trained exclusively to predict protein shapes can also generate new ones.
Approach seeks to expand understanding of biochemical activities common to all animals, plants and fungi
New artificial intelligence software can compute protein structures in 10 minutes.
